ENTA
Enanta Pharmaceuticals, Inc. · Healthcare · Biotechnology
Input momentum (manajer yang sebanding):
keluasan pemegang +6.7% ·
aliran saham -12.3% ·
posisi baru bersih +6.2%
· formula
Fragmentasi kepemilikan: lebih banyak pemegang, kepemilikan agregat yang lebih kecil.
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q3 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 11.84K | $143,216 | n/a | n/a |
| Q2 2026 | 56 | -3 | 10.74M | $156.55M | +2 | −5 |
| Q1 2026 | 62 | -2 | 14.86M | $187.69M | +5 | −7 |
| Q4 2025 | 64 | +3 | 16.10M | $253.79M | +3 | n/a |
| Q3 2025 | 16 | +1 | 7.96M | $95.31M | +2 | −1 |
| Q2 2025 | 12 | 0 | 8.38M | $63.38M | n/a | n/a |
| Q1 2025 | 9 | -2 | 4.49M | $24.81M | n/a | −2 |
| Q4 2024 | 11 | -1 | 4.05M | $23.26M | n/a | −1 |
| Q3 2024 | 11 | +2 | 4.15M | $43.00M | +2 | n/a |
| Q2 2024 | 9 | n/a | 3.87M | $50.19M | n/a | n/a |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (pasif) | 1.94M | -1.9% | $23.21M | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 2 | BlackRock ✦ (pasif) | 1.83M | -0.8% | $21.94M | 0.0% | ▼ Trim | 2 | SEC ↗ ×9 |
| 3 | Millennium Management ✦ | 948.08K | -35.0% | $11.35M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 4 | Geode Capital Management ✦ (pasif) | 493.19K | +1.5% | $5.90M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 5 | Renaissance Technologies ✦ | 479.60K | +2.1% | $5.74M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 6 | State Street Global Advisors ✦ (pasif) | 471.99K | +0.4% | $5.65M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Point72 Asset Management ✦ | 300.00K | Baru | $3.59M | 0.0% | New | 1 | SEC ↗ |
| 8 | Morgan Stanley ✦ | 282.63K | n/a | $3.38M | 0.0% | n/c | 1 | SEC ↗ ×7 |
| 9 | Marshall Wace ✦ | 275.39K | -67.9% | $3.30M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 10 | JPMorgan Chase ✦ | 247.63K | n/a | $2.96M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 11 | AQR Capital Management ✦ | 226.84K | -42.7% | $2.72M | 0.0% | ▼ Trim | 6 | SEC ↗ ×5 |
| 12 | D. E. Shaw & Co. ✦ | 225.74K | -20.0% | $2.70M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 13 | Goldman Sachs Group ✦ | 166.43K | n/a | $1.99M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 14 | Two Sigma Investments ✦ | 60.72K | -22.6% | $726,842 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 10.15K | Baru | $122,000 | 0.0% | New | 1 | SEC ↗ |
| 16 | Fidelity (FMR) ✦ | 1.78K | -0.3% | $21,363 | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
"Their weight" = porsi posisi dari nilai ekuitas 13F yang dilaporkan manajer tersebut: ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Point72 Asset Management | $3.59M | 0.0% |
| T. Rowe Price | $122,000 | 0.0% |
Telah keluar
| Citadel Advisors | $447,129 | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 131 pemegang, 26.72M saham, $290.62M dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang sekuritas ini yang dilacak: jumlah kepemilikan bersama, bukan hubungan fundamental.